arrow
S

Sarah C. Grünert

University of Freiburg
H指数:31
被引数:4,545

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Chain Fatty Acid Oxidation Disorder Genes: A Comprehensive Genetic Database of LC-FAOD Variants, Genotypes, and Phenotypes

长链脂肪酸氧化障碍基因:LC-FAOD变异体、基因型和表型的综合性遗传数据库

2026-07-070
OAAI
Progressive short stature in Pearson syndrome and the impact of organ failure

佩尔森综合征的进行性身材矮小及器官衰竭的影响

2026-05-170
OAAI
Pregnancies in Women With Long-Chain Fatty Acid Oxidation Disorders: Results of a European and North American Survey

患有长链脂肪酸氧化障碍的妇女的妊娠: 欧洲和北美的调查结果

2026-01-190
OAAI
Person-centered outcomes for liver glycogen storage diseases: development of an international consensus-based standard outcome set

以患者为中心的肝脏糖原贮积症结局:基于国际共识标准结局集的开发

2025-09-230
OAAI
Hearing rehabilitation in SERAC1 related MEGD(H)EL syndrome – implications from a multi-center retrospective cohort study

SERAC1相关MEGD(H)EL综合征的听力康复——来自多中心回顾性队列研究的启示

2025-07-210
OAAI
Mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase deficiency: From metabolism to clinical implications

线粒体3-羟基-3-甲基戊二酰辅酶A合酶缺乏症:从代谢到临床意义

2025-06-110
OA
Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn Screening
2024-07-036
PRE
Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b

依帕列净治疗21例糖原贮积病1b婴儿的中性粒细胞减少和中性粒细胞功能障碍

2024-06-011
OAAI
Treatment recommendations for glycogen storage disease type IB-associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop
2024-03-017
OAAI
Neurological outcome in long-chain hydroxy fatty acid oxidation disorders
2024-01-233
OA